Product Information
REPAGLINIDE 0.5 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0761 per EA under NDC 62135094690. Its NADAC has been published 40 times since Sep 24, 2025.
Strength
.5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135094690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
REPAGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078555On Market Since
11/22/2013
Pharmacological Classes
Price Statistics
The NADAC for REPAGLINIDE 0.5 MG TABLET has been published 40 times since Sep 24, 2025, and over the history we have for it it has declined 14.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0761 per EA |
|---|---|
| All-time high | $0.0890 (Nov 12, 2025) |
| All-time low | $0.0723 (Dec 17, 2025) |
| 52-week high | $0.0890 |
| 52-week low | $0.0723 |
| Median price | $0.0796 |
| Average price | $0.0803 |
| Largest weekly change | -10.7% (Nov 19, 2025) |
| Weeks tracked | 40 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of REPAGLINIDE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REPAGLINIDE 0.5 MG TABLET, manufactured by Chartwell RX LLC, is $0.0761 per EA (NDC 62135094690), effective Jun 24, 2026.
How has the price of REPAGLINIDE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for REPAGLINIDE 0.5 MG TABLET has declined 14.2%. It has been tracked across 40 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for REPAGLINIDE 0.5 MG TABLET?
Since Sep 24, 2025, the NADAC for REPAGLINIDE 0.5 MG TABLET has ranged from a low of $0.0723 (Dec 17, 2025) to a high of $0.0890 (Nov 12, 2025), with a median of $0.0796 per EA.
Are there cheaper alternatives to REPAGLINIDE 0.5 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as REPAGLINIDE 0.5 MG TABLET, but none are currently priced below it.
Who manufactures REPAGLINIDE 0.5 MG TABLET?
REPAGLINIDE 0.5 MG TABLET (NDC 62135094690) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification